Cargando…

EGFR mutation-guided use of afatinib, erlotinib and gefitinib for advanced non-small-cell lung cancer in Hong Kong – A cost-effectiveness analysis

INTRODUCTION: Tyrosine kinase inhibitors (TKIs) therapy targets at epidermal growth factor receptor (EGFR) gene mutations in non-small-cell lung cancer (NSCLC). We aimed to compare the EGFR mutation-guided target therapy versus empirical chemotherapy for first-line treatment of advanced NSCLC in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	You, Joyce H. S., Cho, William C. S., Ming, Wai-kit, Li, Yu-chung, Kwan, Chung-kong, Au, Kwok-hung, Au, Joseph Siu-kie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920377/ https://www.ncbi.nlm.nih.gov/pubmed/33647045 http://dx.doi.org/10.1371/journal.pone.0247860

Ejemplares similares

Survival benefits from afatinib compared with gefitinib and erlotinib among patients with common EGFR mutation in first‐line setting
por: Kwok, Wang Chun, et al.
Publicado: (2022)

Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
por: Kim, Youjin, et al.
Publicado: (2019)

Network Meta-Analysis of Erlotinib, Gefitinib, Afatinib and Icotinib in Patients with Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations
por: Liang, Wenhua, et al.
Publicado: (2014)

Comparison of Effectiveness of Gefitinib, Erlotinib, and Afatinib in Advanced Non-small Cell Lung Cancer Patients with EGFR Mutation Positive in Indonesian Population
por: SUTANDYO, Noorwati, et al.
Publicado: (2019)

Novel MAGT1 Mutation Found in the First Chinese XMEN in Hong Kong
por: Au, Elaine Yuen Ling, et al.
Publicado: (2022)

Uses of Antibiotics in Ornamental Fish in Hong Kong and the Antibiotic Resistance in the Associated Zoonotic Pathogens
por: Au-Yeung, Chun, et al.
Publicado: (2022)

Evolution and Control of COVID-19 Epidemic in Hong Kong
por: Wong, Shuk-Ching, et al.
Publicado: (2022)

The Role of Brain Radiotherapy before First-Line Afatinib Therapy, Compared to Gefitinib or Erlotinib, in Patients with EGFR-Mutant Non–Small Cell Lung Cancer
por: Jung, Hyun Ae, et al.
Publicado: (2023)

Consensus statements on the clinical understanding and use of bupropion in Hong Kong
por: Lee, Wing‐King, et al.
Publicado: (2021)

The Seasonality of Respiratory Viruses in a Hong Kong Hospital, 2014–2023
por: Chan, Wai-Sing, et al.
Publicado: (2023)

Synergistic Effect of Afatinib with Su11274 in Non-Small Cell Lung Cancer Cells Resistant to Gefitinib or Erlotinib
por: Chen, Gang, et al.
Publicado: (2013)

Are Current or Future Mesothelioma Epidemics in Hong Kong the Tragic Legacy of Uncontrolled Use of Asbestos in the Past?
por: Tse, Lap Ah, et al.
Publicado: (2010)

Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
por: You, Joyce HS, et al.
Publicado: (2014)

Epithelial Transfer of the Tyrosine Kinase Inhibitors Erlotinib, Gefitinib, Afatinib, Crizotinib, Sorafenib, Sunitinib, and Dasatinib: Implications for Clinical Resistance
por: Honeywell, Richard J., et al.
Publicado: (2020)

A Retrospective Comparison of the Clinical Efficacy of Gefitinib, Erlotinib, and Afatinib in Japanese Patients With Non-Small Cell Lung Cancer
por: Fujiwara, Atsushi, et al.
Publicado: (2018)

Efficacy and dose of afatinib in patients with non‐small cell lung cancer after failure of prior gefitinib or erlotinib treatment
por: Choi, Hayoung, et al.
Publicado: (2021)

Epidemiology of multidrug-resistant organisms before and during COVID-19 in Hong Kong
por: Wong, Shuk-Ching, et al.
Publicado: (2023)

Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
por: Schuler, M., et al.
Publicado: (2016)

Continuation of Dabigatran Therapy in “Real-World” Practice in Hong Kong
por: Ho, Mei Han, et al.
Publicado: (2014)

Shikonin sensitizes wild-type EGFR NSCLC cells to erlotinib and gefitinib therapy
por: Li, Yang-Ling, et al.
Publicado: (2018)

Seasonal influenza vaccine effectiveness at primary care level, Hong Kong SAR, 2017/2018 winter
por: Chan, Yung-wai Desmond, et al.
Publicado: (2018)

Cognitive-behavioral group program for Chinese heterosexual HIV-infected men in Hong Kong
por: Chan, Iris, et al.
Publicado: (2005)

Overall survival of patients with EGFR mutation-positive non-small-cell lung cancer treated with erlotinib, gefitinib or afatinib under drug programmes in Poland – real-world data
por: Brzozowska, Melania, et al.
Publicado: (2019)

Treatment Adherence and Health-Related Quality of Life in Patients with Hemophilia in Hong Kong
por: Cheung, Yin Ting, et al.
Publicado: (2022)

Cost-effectiveness analysis of chromosomal microarray as a primary test for prenatal diagnosis in Hong Kong
por: Chung, Claudia Ching Yan, et al.
Publicado: (2020)

Inequalities in Psychiatric Morbidity in Hong Kong and Strategies for Mitigation
por: Chan, Siu-Ming, et al.
Publicado: (2022)

Prospective study on human fecal carriage of Enterobacteriaceae possessing mcr-1 and mcr-2 genes in a regional hospital in Hong Kong
por: Chan, Wai-Sing, et al.
Publicado: (2018)

Explosive outbreak of SARS-CoV-2 Omicron variant is associated with vertical transmission in high-rise residential buildings in Hong Kong
por: Cheng, Vincent Chi-Chung, et al.
Publicado: (2022)

Risk assessment and prediction for lung cancer among Hong Kong Chinese men
por: Tse, Lap Ah, et al.
Publicado: (2022)

Hong Kong Registry Report 2004
por: Ho, Yiu-Wing, et al.
Publicado: (2005)

Psychometric properties of the Children’s Response Styles Questionnaire in a Hong Kong Chinese community sample
por: Lo, Barbara Chuen Yee, et al.
Publicado: (2017)

Predicting Tumor Responses to Gefitinib and Erlotinib
Publicado: (2005)

Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong
por: Peng, Qiaoli, et al.
Publicado: (2022)

Noise Exposure and Hearing Impairment among Chinese Restaurant Workers and Entertainment Employees in Hong Kong
por: Lao, Xiang Qian, et al.
Publicado: (2013)

COVID-19 outbreaks in residential care homes in Hong Kong and effectiveness of vaccine against severe outcomes
por: Leung, Mei Hung Joanna, et al.
Publicado: (2023)

Contribution of low population immunity to the severe Omicron BA.2 outbreak in Hong Kong
por: Chen, Lin-Lei, et al.
Publicado: (2022)

Increased Genetic Diversity of HIV-1 Circulating in Hong Kong
por: Chen, Jonathan Hon-Kwan, et al.
Publicado: (2010)

Characteristics of Maternal Mortality Missed by Vital Statistics in Hong Kong, 2000-2019
por: Cheung, Ka Wang, et al.
Publicado: (2023)

Latent Tuberculosis Infection Testing Strategies for HIV-Positive Individuals in Hong Kong
por: Wong, Ngai Sze, et al.
Publicado: (2019)

Real-World Perspectives From Surgeons and Oncologists on Resectability Definition and Multidisciplinary Team Discussion of Stage III NSCLC in People’s Republic of China, Hong Kong, and Macau: A Physician Survey
por: Lee, Victor Ho-Fun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r51bt0ll1a47hit17vv8j1vu1b